clinion

Insights / Awards

Clinion Named Finalist at the 2025 Citeline Awards for Innovation in Clinical Trials

Clinion Named Finalist at the 2025 Citeline Awards
At Clinion, we are redefining the future of clinical trials through AI and automation, and we are proud to announce our recognition as a finalist at the 2025 Citeline Awards Agentic AI-powered Data Review. This recognition highlights Clinion’s leadership as the industry embraces AI-driven execution across the entire clinical trial lifecycle.

The Innovation That Won Recognition

Clinion’s AI-powered Data Review technology was recognized for transforming how clinical data is managed throughout the trial lifecycle. Our solution eliminates the three fundamental barriers in clinical trials: data review delays that stretch timelines, operational costs driven by resource-heavy manual work, and compliance risks inherent in traditional workflows. Where traditional platforms force teams to choose between speed, cost, and quality, Clinion delivers it all.

Why Clinion Stands Out

Natural language querying for instant data listings

Teams can create any data listing in seconds simply by typing what they want to see. The AI interprets the request, retrieves the relevant information, and presents it instantly. This eliminates the need for programming support, enabling Data Managers to make decisions much faster.

 

Integrated query management directly from listings

Users can review generated listings and flag discrepancies immediately. Queries can be created and submitted directly within the EDC System from the same screen, eliminating unnecessary navigation and reducing the time spent resolving issues.

 

AI-driven automation across the data lifecycle

Clinion’s AI capabilities support every major step of data management, from mapping study data to CDISC standards to generating reports and ensuring accurate medical coding. By automating these key activities, the platform significantly reduces manual effort and shortens study timelines.

 

Seamless integration within a unified eClinical platform

The solution is built directly into Clinion’s unified platform, allowing users to manage data review without switching between tools. This approach improves accuracy, simplifies training, and ensures teams always work from a single, consistent source of trial data.


CEO Quote

A quote by ceo of clinion manuj vangipurapu
A quote by CEO of Clinion manuj Vangipurapu


Proven Impact

Faster data listing generation

0 %

Faster query resolution

0 %

Cost reduction

0 %


Why This Matters

Clinion’s approach is not about replacing Data Managers; it’s about removing delays and empowering teams. AI-driven automation accelerates trial workflows, improves data accuracy, and enables faster decision-making, ultimately helping get treatments to patients sooner while maintaining the highest standards of oversight.

Unlock the Future of Clinical Trials with Clinion.

Cut your trial costs by 35% and accelerate your time-to-market by 30%

Compliance

Fully Compliant with Global Standards

FDA,HIPAA and ISO Logos
ich ,gdpr ,eu compliant logos
Clinion’s adherence to global regulatory standards including FDA 21 CFR Part 11, HIPAA, ISO 9001:2015, ISO 27001:2013, ICH, GDPR, and EU Annex 11.